• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hodgkin's disease: a flow cytometric study.霍奇金淋巴瘤:流式细胞术研究
J Clin Pathol. 1988 Apr;41(4):365-9. doi: 10.1136/jcp.41.4.365.
2
Prognostic value of DNA ploidy and proliferative activity in Hodgkin's disease.DNA倍体和增殖活性在霍奇金病中的预后价值
Am J Clin Pathol. 1988 Dec;90(6):670-3. doi: 10.1093/ajcp/90.6.670.
3
[DNA content of lymphocytes and mononuclear tumor cells in Hodgkin's disease].
Klin Wochenschr. 1985 Jul 15;63(14):631-5. doi: 10.1007/BF01732858.
4
Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.流式细胞术检测的S期细胞分数作为非霍奇金淋巴瘤细胞学分级的补充生物学参数。
Diagn Cytopathol. 2003 Oct;29(4):194-9. doi: 10.1002/dc.10298.
5
DNA content in non-Hodgkin's lymphoma. Comparison between flow cytometry and cytogenetics in fresh and paraffin-embedded tissue.非霍奇金淋巴瘤中的DNA含量。新鲜组织和石蜡包埋组织中流式细胞术与细胞遗传学的比较。
Acta Oncol. 1994;33(6):621-5. doi: 10.3109/02841869409121772.
6
Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Haematologica. 1997 May-Jun;82(3):281-5.
7
DNA aneuploidy in Hodgkin's disease: a multiparameter flow cytometric analysis.霍奇金淋巴瘤中的DNA非整倍体:多参数流式细胞术分析
Leuk Lymphoma. 1994 Jan;12(3-4):297-306. doi: 10.3109/10428199409059602.
8
Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Cancer Res. 1988 Nov 15;48(22):6608-13.
9
Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).儿童非霍奇金淋巴瘤(NHL)和霍奇金病(HD)的倍性及增殖活性分析。
Pediatr Pathol Lab Med. 1997 Nov-Dec;17(6):893-902.
10
Prognostic indicators in centroblastic-centrocytic lymphoma.中心母细胞-中心细胞性淋巴瘤的预后指标
J Clin Pathol. 1988 Aug;41(8):866-70. doi: 10.1136/jcp.41.8.866.

引用本文的文献

1
Proliferating cell nuclear antigen (PCNA), p53 and MDM2 expression in Hodgkins disease.霍奇金淋巴瘤中增殖细胞核抗原(PCNA)、p53和MDM2的表达
Sao Paulo Med J. 2007 Mar 1;125(2):77-84. doi: 10.1590/s1516-31802007000200003.
2
Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.霍奇金病中增殖细胞核抗原(PCNA)和核仁组织区:与形态学的相关性
J Clin Pathol. 1993 May;46(5):446-9. doi: 10.1136/jcp.46.5.446.
3
Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.与爱泼斯坦-巴尔病毒相关的恶性肿瘤和良性淋巴结病中的核DNA数量。
J Clin Pathol. 1989 Jul;42(7):699-704. doi: 10.1136/jcp.42.7.699.
4
Review: assessment of cell proliferation in histological material.综述:组织学材料中细胞增殖的评估
J Clin Pathol. 1990 Mar;43(3):184-92. doi: 10.1136/jcp.43.3.184.
5
Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.霍奇金淋巴瘤与CD30阳性间变性大细胞淋巴瘤——恶性疾病的连续谱系。一项定量形态计量学与免疫组织学研究。
Am J Pathol. 1990 Nov;137(5):1047-57.

本文引用的文献

1
Analysis of grade 1 Hodgkin's disease (Report no 6).1级霍奇金病分析(报告第6号)
Clin Radiol. 1981 Sep;32(5):491-8. doi: 10.1016/s0009-9260(81)80174-2.
2
Enhanced uptake of actinomycin D in the dog kidney by simultaneous injection of degradable starch microspheres into the renal artery.通过同时向肾动脉注射可降解淀粉微球增强犬肾中放线菌素D的摄取。
Cancer. 1982 Jul 1;50(1):1-5. doi: 10.1002/1097-0142(19820701)50:1<1::aid-cncr2820500102>3.0.co;2-z.
3
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.使用流式细胞术分析石蜡包埋病理材料细胞DNA含量的方法。
J Histochem Cytochem. 1983 Nov;31(11):1333-5. doi: 10.1177/31.11.6619538.
4
The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report no. 22).结节硬化型霍奇金淋巴瘤细胞亚型的预后意义:271例非剖腹手术病例分析(英国国家淋巴瘤调查组报告第22号)
Clin Radiol. 1983 Sep;34(5):497-501. doi: 10.1016/s0009-9260(83)80148-2.
5
Hodgkin's cell lines: characteristics and possible pathogenetic implications.霍奇金细胞系:特征及可能的发病机制意义
Hematol Oncol. 1983 Apr-Jun;1(2):139-47. doi: 10.1002/hon.2900010204.
6
The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.非霍奇金淋巴瘤中肿瘤生长的生物学特性。220例病例的双参数流式细胞术研究。
J Clin Invest. 1984 Apr;73(4):1201-14. doi: 10.1172/JCI111306.
7
Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology.DNA细胞计量学命名法公约。分析细胞学会命名委员会
Cancer Genet Cytogenet. 1984 Oct;13(2):181-3. doi: 10.1016/0165-4608(84)90059-1.
8
Establishment and characterization of a cloned giant cell line from a patient with Hodgkin's disease.从一名霍奇金病患者建立并鉴定克隆的巨细胞系。
J Natl Cancer Inst. 1984 Oct;73(4):809-30.
9
The pathology and nomenclature of Hodgkin's disease.霍奇金病的病理学及命名
Cancer Res. 1966 Jun;26(6):1063-83.
10
A clinicopathological study of nodular sclerosing Hodgkin's disease.结节硬化型霍奇金淋巴瘤的临床病理研究
J Clin Pathol. 1968 May;21(3):303-10. doi: 10.1136/jcp.21.3.303.

霍奇金淋巴瘤:流式细胞术研究

Hodgkin's disease: a flow cytometric study.

作者信息

Morgan K G, Quirke P, O'Brien C J, Bird C C

机构信息

Department of Pathology, University of Leeds.

出版信息

J Clin Pathol. 1988 Apr;41(4):365-9. doi: 10.1136/jcp.41.4.365.

DOI:10.1136/jcp.41.4.365
PMID:3366919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1141457/
Abstract

Flow cytometry was performed on paraffin embedded tissue from 115 cases of Hodgkin's disease. Thirteen (11%) tumours were aneuploid with no significant difference between the histological subgroups. The median proliferative index was 14%, and the highest values were found in the NS2 (16.4%) and lymphocyte depleted (16.0%) subgroups. The difference in proliferative index approached significance when the NS2 subgroup was compared with the NS1 subgroup (p less than or equal to 0.11) and when the lymphocyte depleted and NS2 subgroups combined were compared with the mixed cellularity, lymphocyte predominance, and NS1 subgroups combined (p less than or equal to 0.07). There was a trend towards better survival for patients with aneuploid tumours and those cases with a proliferative index below 15%, but neither of these trends was significant.

摘要

对115例霍奇金病石蜡包埋组织进行了流式细胞术检测。13例(11%)肿瘤为非整倍体,各组织学亚组之间无显著差异。增殖指数中位数为14%,在NS2亚组(16.4%)和淋巴细胞消减亚组(16.0%)中值最高。当NS2亚组与NS1亚组比较时(p≤0.11),以及当淋巴细胞消减亚组和NS2亚组合并与混合细胞型、淋巴细胞为主型和NS1亚组合并比较时(p≤0.07),增殖指数差异接近显著。非整倍体肿瘤患者以及增殖指数低于15%的患者有生存更好的趋势,但这两种趋势均不显著。